Asia Pacific Genomics Market Size & Outlook, 2023-2030
Asia Pacific genomics market, 2018-2030 (US$M)
Related Markets
Asia Pacific genomics market highlights
- The Asia Pacific genomics market generated a revenue of USD 6,156.4 million in 2023.
- The market is expected to grow at a CAGR of 18.1% from 2024 to 2030.
- In terms of segment, functional genomics was the largest revenue generating application in 2023.
- Pathway Analysis is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 6,156.4 million |
| Market revenue in 2030 | USD 19,759.5 million |
| Growth rate | 18.1% (CAGR from 2023 to 2030) |
| Largest segment | Functional genomics |
| Fastest growing segment | Pathway Analysis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
| Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.9% of the global genomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 19,759.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genomics Market Scope
Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.2% in 2023. Horizon Databook has segmented the Asia Pacific genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
High acceptance of sequencing based diagnostics platforms among practicing oncologists. Increasing healthcare spending by government and rising per capita income are among the factors expected to significantly boost the adoption of genome sequencing.
High proportion of low-income groups in Asia Pacific is anticipated to restrain the market growth. High cost coupled with technology is acting as a major threat to market growth.
Reasons to subscribe to Asia Pacific genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific genomics market databook
-
Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific genomics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific genomics market size, by country, 2018-2030 (US$M)
Asia Pacific Genomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
